After finishing at $28.71 in the prior trading day, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $27.55, down -4.04%. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 721255 shares were traded.
Ratios:
Our goal is to gain a better understanding of RCKT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.80 and its Current Ratio is at 7.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on October 24, 2023, initiated with a Overweight rating and assigned the stock a target price of $65.
On February 01, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $53.Canaccord Genuity initiated its Buy rating on November 08, 2022, with a $53 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 29 when Militello John sold 10,000 shares for $29.84 per share. The transaction valued at 298,450 led to the insider holds 21,517 shares of the business.
Wilson Martin sold 4,100 shares of RCKT for $120,257 on Feb 29. The General Counsel now owns 18,680 shares after completing the transaction at $29.33 per share. On Feb 16, another insider, Shah Gaurav, who serves as the CEO of the company, sold 20,272 shares for $29.84 each. As a result, the insider received 604,876 and left with 554,762 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 2.49B and an Enterprise Value of 2.14B.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $14.89. The 50-Day Moving Average of the stock is 29.04, while the 200-Day Moving Average is calculated to be 22.25.
Shares Statistics:
The stock has traded on average 844.40K shares per day over the past 3-months and 826.15k shares per day over the last 10 days, according to various share statistics. A total of 90.28M shares are outstanding, with a floating share count of 82.66M. Insiders hold about 8.67% of the company’s shares, while institutions hold 95.48% stake in the company. Shares short for RCKT as of Feb 15, 2024 were 9.2M with a Short Ratio of 10.89, compared to 8.25M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.19% and a Short% of Float of 13.28%.
Earnings Estimates
Its stock is currently analyzed by 10 different market analysts. On average, analysts expect EPS of -$0.69 for the current quarter, with a high estimate of -$0.5 and a low estimate of -$0.83, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.49 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$1.95 and -$3.38 for the fiscal current year, implying an average EPS of -$2.8. EPS for the following year is -$2.04, with 11 analysts recommending between -$0.5 and -$3.17.
Revenue Estimates
Based on 10 analysts’ estimates, the company’s revenue will be $167.81M in the next fiscal year. The high estimate is $325.82M and the low estimate is $23.1M. The average revenue growth estimate for next year is up 751.80% from the average revenue estimate for this year.
